コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 st step in the processes of 'sentience' and 'irritability'.
2 ued all study drugs due to an adverse event (irritability).
3 es were associated with decreasing levels of irritability.
4 ver, tachycardia, poor perfusion, and severe irritability.
5 and libido, and with anorexia, fatigue, and irritability.
6 ying the sensitisation of C-fibres in airway irritability.
7 disordered breathing and reduces ventricular irritability.
8 tems related to anger, worry, dysphoria, and irritability.
9 ious mood symptoms, ie, sadness, crying, and irritability.
10 stories of impulsive aggressive behavior and irritability.
11 y index were used as dimensional measures of irritability.
12 ts include depressive symptoms, anxiety, and irritability.
13 frustration) blocks predicted child-reported irritability.
14 as conducted to identify networks predicting irritability.
15 ression models to estimate associations with irritability.
16 s same network was associated with increased irritability.
17 s was more pronounced in young children with irritability.
18 regulation may in part underlie symptoms of irritability.
19 schizophrenia risk score with psychosis and irritability.
20 pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction
22 .001), anxiety (3.00; 2.01-4.48; P < .001), irritability 2.99; 2.11-4.22; P < .001), and depression
23 crocephaly (41%), nausea and vomiting (30%), irritability (24%), and lethargy (21%) for children aged
24 performed in 45 patients with mTBI (38 with irritability, 32 with depression, and 18 with anxiety).
25 (48%), fatigue (46%), drowsiness (39%), and irritability (37%); most scores indicated high distress.
26 ), disinhibition (16% versus 2%, P = 0.009), irritability (48% versus 9%, P = 0.0001), sleep changes
28 stic specificity in the neural correlates of irritability, a symptom of both DMDD and bipolar disorde
29 ates consistently captured shared aspects of irritability, ADHD, and anxiety, while the third was spe
30 sed on early (baseline-to-week-2) changes in irritability after controlling for early changes in over
31 th enhancing dopamine signaling (increase of irritability, aggression, etc.), is the main cause of Ca
32 onal manifestations often including anxiety, irritability/aggression and altered sensory processing.
35 five neuropsychiatric features: depression, irritability/aggression, obsessive/compulsive behaviours
36 ng post-traumatic stress symptoms (PTSS) are irritability, aggressive behavior, distressing memories
37 severe dysphoria, behavioural disinhibition, irritability/agitation, reduced empathy/sympathy, repeti
40 vioral and psychophysiological correlates of irritability among children with severe mood dysregulati
42 ed in a sustained reduction in scores on the Irritability and Aggression subscales of the Overt Aggre
43 Given that psychiatric changes, including irritability and aggression, are common findings in HD p
44 dications are indicated for the treatment of irritability and agitation symptoms in children with aut
48 s analyses, the shared and unique effects of irritability and anxiety were tested on amygdala functio
49 2 major dimensions of child psychopathology, irritability and anxiety, on neural responses to facial
54 symptoms, including depressed mood, anxiety, irritability and craving in dependent subjects may contr
56 ) was significantly higher than that between irritability and delinquency (r(A)=0.57, 95% CI=0.45-0.6
57 ) was significantly higher than that between irritability and delinquency (r(A)=0.57, 95% CI=0.45-0.6
58 ic analyses, the genetic correlation between irritability and depression (r(A)=0.70, 95% CI=0.59-0.82
59 ic analyses, the genetic correlation between irritability and depression (r(A)=0.70, 95% CI=0.59-0.82
61 the hypothesis that the association between irritability and depression is accounted for by genetic
62 y exacerbate, or even cause symptoms such as irritability and depression that are common in early sta
64 nd bipolar disorder showed similar levels of irritability and did not differ from each other or from
65 uana relapse and reversed withdrawal-related irritability and disruptions in sleep and food intake (p
67 tween the two components of oppositionality (irritability and headstrong/hurtful behaviors) and depre
68 roversy exists regarding whether nonepisodic irritability and hyperarousal (severe mood dysregulation
69 severe mood dysregulation (i.e., nonepisodic irritability and hyperarousal without episodes of euphor
71 (PTE) affected speech processing, levels of irritability and hypertonicity, attention levels, abilit
72 cept for a significantly greater decrease in irritability and improvement in motor inhibition in sham
74 side effects experienced by women using HC (irritability and lability) are not captured by a screeni
76 thic electromyogram with abnormal electrical irritability and muscle biopsy findings of myofibrillar
77 RI) paradigm to examine associations between irritability and neural activation and tested the modera
81 bacute encephalopathy with motor regression, irritability and stupor or coma resulting in major handi
82 aluated the longitudinal association between irritability and suicidal ideation (SI) in adults with m
84 that is, those who have severe, nonepisodic irritability and the hyperarousal symptoms characteristi
86 s known about genetic influences on juvenile irritability and whether such influences are development
90 equate growth, reduced reporting of colic or irritability, and a lower frequency of antibiotic use.
95 anifests with pediatric symptoms of anxiety, irritability, and attention-deficit/hyperactivity disord
98 1 or more elevated subscales (inflexibility, irritability, and difficulty with routines) at 6 months.
99 rted high levels of household strain, social irritability, and financial strain as well as limitation
103 ulsive disorder, tics, anxiety, mood swings, irritability, and restricted eating is described in chil
104 reativity, connectedness, energy, happiness, irritability, and wellness on dose days compared with no
106 ies as well as moderately strong links among irritability (anger), concentration deficits, and sleep
107 -sectional investigations and indicates that irritability/anger during MDEs is a highly prevalent cli
110 ion, included reductions in the frequency of irritability, anxiety, and delusions; among patients who
111 ower total withdrawal symptom score and less irritability, anxiety, craving, and restlessness than pl
113 routines (aOR, 1.64; 95% CI, 1.05-2.57), and irritability (aOR, 1.86; 95% CI, 1.13-3.08) than childre
114 vey items related to anger, self-confidence, irritability, appetite, and interest in leisure activiti
117 lementary conceptualizations of pathological irritability are proposed: 1) aberrant emotional and beh
119 odel analyses were used to assess changes in irritability (as measured with the five-item irritabilit
120 ficantly in post hoc analysis of anxiety and irritability, as well as GI health, after 8 weeks of tre
123 sectional and longitudinal associations with irritability at follow-up were evaluated using generaliz
125 l models, the phenotypic association between irritability at wave 2 and depression at wave 3 was acco
128 ncy (beta -0.032, OR 1.10 [1.02-1.20]), more irritability (beta 0.032, OR 1.07 [1.01-1.14]), and more
130 y decreased locomotor activity and increased irritability but had no effect on sexual behavior, partn
132 tate cancer is followed by bowel and bladder irritability, by increasingly severe sexual dysfunction
133 cally and pathophysiologically distinct, yet irritability can be a clinical feature of both illnesses
134 ation had a slower progression in chorea and irritability compared with those not taking such medicat
135 Behavioral measures included locomotion, irritability, copulation, partner preference, and aggres
138 scent Development reported on the children's irritability, defined using a previously identified scal
140 sorder characterized by personality changes, irritability, depression, seizures, memory loss and some
141 ncluded dissociation and symptoms of "limbic irritability," depression, anxiety, and anger-hostility.
143 mine whether the neural mechanisms mediating irritability differ between bipolar disorder and DMDD, u
144 ild Behavior Checklist: physical aggression, irritability, disobedient behavior, and delinquent behav
145 sample of 195 youths with varying levels of irritability (disruptive mood dysregulation disorder, N=
146 ut the trial between irritability (five-item irritability domain of Concise Associated Symptom Tracki
147 irritability (as measured with the five-item irritability domain of the Concise Associated Symptom Tr
148 5% CI, 0.96-1.25] points; P = .02) and Anger/Irritability DRSP subscale score (1.22 [95% CI, 1.05-1.4
149 tivation analyses revealed associations with irritability during attention orienting following frustr
154 n and hyperactivity-impulsivity, whereas the irritability factor shared genetic influences uniquely w
155 severe epilepsy including infantile spasms, irritability, failure to thrive, and stereotypic hand mo
156 ent association throughout the trial between irritability (five-item irritability domain of Concise A
157 = 9) presented in early infancy with severe irritability, followed by dystonia and stagnation of dev
158 growth restriction, infantile hypotonia, and irritability, followed by failure to thrive and short st
161 question of whether social communication and irritability have the same meaning at different ages.
162 xiety (hazard ratio=1.87, 95% CI=1.28-2.73), irritability (hazard ratio=1.84, 95% CI=1.31-2.58), and
163 ated to visual hallucinatory experiences and irritability, implying that these experiences become mor
166 with behavioural disorders characterized by irritability, impulsiveness, bizarre alterations in dres
168 baseline emotional and behavioral disorders, irritability in adolescence predicted major depressive d
174 les, with new genetic risk factors affecting irritability in early and late adolescence for males.
175 ttle is known about the relationship between irritability in early life and its outcomes in mid-adult
179 ia was associated with significantly greater irritability in univariate regression models (for more t
180 community samples indicate that nonepisodic irritability in youths is common and is associated with
183 e hypothesis that there are several forms of irritability, including a "neurodevelopmental/ADHD-like"
185 ionally associated with depressive symptoms, irritability, increased right cerebellum exterior volume
187 eficiency have included depression, anxiety, irritability, insomnia, weakness, diminished libido, imp
197 Collectively, these findings suggest that irritability is associated with widespread reductions in
199 his study examines the extent to which youth irritability is related to adult psychiatric outcomes by
201 he Aberrant Behavior Checklist subscales for irritability, lethargy/social withdrawal, and hyperactiv
202 itioned to produce migraine symptoms such as irritability, loss of appetite, fatigue, depression, or
203 rvasive antisocial character traits, such as irritability, manipulativeness, and lack of remorse.
205 ts conceptualization: early-onset persistent irritability may be more neurodevelopmental/ADHD-like an
206 ype bipolar disorder, the pathophysiology of irritability may differ among the groups and is influenc
207 essed mothers with high anxious distress and irritability may require medications that reduce these s
208 For affective symptoms (anxiety, sadness, irritability, mood swings), there were significant main
210 lessness, fatigue, difficulty concentrating, irritability, muscle tension, or sleep disturbances).
211 arly perimenopausal women had higher odds of irritability, nervousness, and frequent mood changes but
212 ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive de
215 utward currents could also contribute to the irritability of the central nervous system typical of cl
216 maternal stroking was associated with higher irritability, only in the mismatched, low-high and high-
217 reased rates of behavior problems, including irritability, oppositional defiant behavior, conduct dis
219 escence, unit experiences, health, injuries, irritability or anger, personality, emotional problems,
220 a extend prior work conducted in youths with irritability or anxiety alone and suggest that research
223 ome characterized by episodic acute onset of irritability or neurological deficits between 2 months a
224 od regulation problems in the form of either irritability or short episodes of mania-like symptoms in
225 regulation problems, such as severe chronic irritability or short episodes of mania-like symptoms, a
226 esses may be effective for cases with severe irritability or short episodes of mania-like symptoms.
227 he evidence base for the treatment of either irritability or short-lived episodes of mania-like sympt
228 characteristic of asthma is increased airway irritability, or bronchial hyperresponsiveness (BHR) whi
230 ania is accompanied by symptoms of euphoria, irritability, or excitation, whereas depression is assoc
231 uch as mood stabilizers, which dampen limbic irritability, or selective serotonin reuptake inhibitors
233 with a lower frequency of reported colic or irritability (P < 0.001) and a lower frequency of antibi
234 or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptom
236 itory hallucinations, visual hallucinations, irritability, personality change, and rapid eye movement
237 Greater baseline-to-week-2 reductions in irritability predicted lower levels of subsequent SI; es
240 we examined how transdiagnostic symptoms of irritability relate to the development of structural bra
243 threat are central to the pathophysiology of irritability, revealing important translational opportun
244 Clinicians and researchers should assess irritability routinely, and specific assessment tools ar
247 reduction in several core PMDD symptoms (ie, irritability, sadness, anxiety, food cravings, and bloat
248 ned as at least a 25 percent decrease in the Irritability score and a rating of much improved or very
249 resulted in a 56.9 percent reduction in the Irritability score, as compared with a 14.1 percent decr
251 lly in diabetic patients, such as confusion, irritability, seizure and can even be fatal in specific
252 elessness, anhedonia/lack of energy, anxiety/irritability, self-reproach, disturbed sleep, agitation/
254 al and genetic findings suggest that chronic irritability should be regarded as a mood problem that i
256 f frustration, children with severe, chronic irritability showed abnormally reduced activation in reg
257 terised by feelings of threat, restlessness, irritability, sleep disturbance, and tension, and sympto
258 degrees F, pericardial friction rub, patient irritability, small pericardial +/- pleural effusion.
259 search is needed to relate these findings to irritability specifically, rather than to other clinical
261 ompared with 22% [SD=32]) and the DRSP anger/irritability subscale (47% [SD=21] compared with 23% [SD
262 resulted in significant improvements on ABC irritability subscale (F = 6.80; p < .001; d = .96).
263 ry outcomes: the Aberrant Behavior Checklist-Irritability subscale (range, 0-45) and the Home Situati
265 At week 24, the Aberrant Behavior Checklist-Irritability subscale declined 47.7% in parent training
266 imary outcome measures were the score on the Irritability subscale of the Aberrant Behavior Checklist
267 l measure (Aberrant Behavior Checklist [ABC] irritability subscale) and safety measures were performe
269 Mood and behavioural symptoms, including irritability, tension, depressed mood, tearfulness, and
270 , the authors present a mechanistic model of irritability that integrates clinical and translational
271 ache, sleep disturbance, inability to relax, irritability) that does not resolve by resting or relaxi
273 athology during their lifetime, varying from irritability to psychosis, but prevalences of particular
276 tern of genetic and environmental effects on irritability using data from a prospective, four-wave lo
277 ith high levels of anxiety but low levels of irritability (Wald chi21 = 21.3; P < .001 for contrast).
278 uch thoughts on a subsequent survey, greater irritability was also associated with greater likelihood
282 dication use, and total intracranial volume, irritability was associated with smaller volumes in prim
289 premenstrual-related tiredness, sadness, and irritability were assessed twice over 6 years in 1,312 m
290 am, associations between neural activity and irritability were found more consistently in the DMDD gr
293 ociated with high levels of both anxiety and irritability, whereas increased connectivity was associa
297 , concurrently) and whether early changes in irritability with antidepressant treatment predict subse
299 24 covariance networks were associated with irritability, with higher levels of irritability being a
300 othesized that during face emotion labeling, irritability would be associated with dysfunctional acti